Cargando…
Development of a Metastatic Uveal Melanoma Prognostic Score (MUMPS) for Use in Patients Receiving Immune Checkpoint Inhibitors
SIMPLE SUMMARY: This is a retrospective cohort study of metastatic uveal melanoma patients. This study undertook to identify clinical characteristics that were predictive and prognostics of benefit to immune checkpoint inhibitors in patients with metastatic uveal melanoma. We developed a Metastatic...
Autores principales: | Kelly, Deirdre, Rose, April A. N., Muniz, Thiago Pimentel, Hogg, David, Butler, Marcus O., Saibil, Samuel D., King, Ian, Kamil, Zaid Saeed, Ghazarian, Danny, Ross, Kendra, Iafolla, Marco, Araujo, Daniel V., Waldron, John, Laperriere, Normand, Krema, Hatem, Spreafico, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8306971/ https://www.ncbi.nlm.nih.gov/pubmed/34298857 http://dx.doi.org/10.3390/cancers13143640 |
Ejemplares similares
-
Biologic subtypes of melanoma predict survival benefit of combination anti-PD1+anti-CTLA4 immune checkpoint inhibitors versus anti-PD1 monotherapy
por: Rose, April A N, et al.
Publicado: (2021) -
Unusual Orange-Colored Choroidal Metastases
por: Krema, Hatem, et al.
Publicado: (2013) -
Real World Outcomes and Hepatotoxicity of Infliximab in the Treatment of Steroid-Refractory Immune-Related Adverse Events
por: Araujo, Daniel V., et al.
Publicado: (2021) -
Radiation therapy for primary orbital and ocular adnexal lymphoma
por: Pereira-Da Silva, Maria Valeria, et al.
Publicado: (2022) -
Immune Checkpoint Inhibitors in Advanced Cutaneous Squamous Cell Carcinoma: Real-World Experience from a Canadian Comprehensive Cancer Centre
por: Koch Hein, Erica C., et al.
Publicado: (2023)